UNICA IRIS Institutional Research Information System

BALBONI, GIANFRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 153.369
NA - Nord America 12.299
AS - Asia 4.318
SA - Sud America 732
AF - Africa 94
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 170.825
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 150.432
US - Stati Uniti d'America 12.193
SG - Singapore 1.882
CN - Cina 1.600
UA - Ucraina 976
SE - Svezia 643
BR - Brasile 617
GB - Regno Unito 405
DE - Germania 277
FI - Finlandia 274
VN - Vietnam 242
IN - India 131
FR - Francia 126
KR - Corea 124
HK - Hong Kong 96
RU - Federazione Russa 66
CA - Canada 64
AR - Argentina 47
JP - Giappone 30
NL - Olanda 30
BD - Bangladesh 28
ES - Italia 26
MX - Messico 26
AT - Austria 24
IQ - Iraq 23
MA - Marocco 23
BE - Belgio 21
ID - Indonesia 21
PL - Polonia 18
EC - Ecuador 17
KH - Cambogia 17
IL - Israele 15
CO - Colombia 14
ZA - Sudafrica 14
PK - Pakistan 13
VE - Venezuela 13
MU - Mauritius 12
EG - Egitto 11
KZ - Kazakistan 11
CL - Cile 10
SA - Arabia Saudita 10
NP - Nepal 8
TR - Turchia 8
UZ - Uzbekistan 8
DZ - Algeria 7
LT - Lituania 7
AZ - Azerbaigian 6
HU - Ungheria 6
IE - Irlanda 6
KE - Kenya 6
PY - Paraguay 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CH - Svizzera 5
JO - Giordania 5
LB - Libano 5
NG - Nigeria 5
PE - Perù 5
DO - Repubblica Dominicana 4
PH - Filippine 4
SN - Senegal 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EU - Europa 3
GE - Georgia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
NO - Norvegia 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
Totale 170.817
Salva come PNG Salva come JPEG
Città #
Cagliari 143.990
Uta 5.881
Fairfield 1.226
Woodbridge 1.039
Houston 1.036
Chandler 978
Ashburn 973
Singapore 891
Boardman 738
Dallas 640
Ann Arbor 538
Wilmington 522
Jacksonville 519
Seattle 499
Cambridge 465
Nyköping 353
Hefei 232
Beijing 224
Nanjing 185
Los Angeles 181
Boston 178
Dearborn 131
Santa Clara 123
Buffalo 118
Seoul 117
Helsinki 100
San Diego 100
Hong Kong 84
Milan 84
Shanghai 84
Dong Ket 66
The Dalles 66
Nanchang 57
Mountain View 56
Shenyang 55
Redwood City 52
Verona 52
Ho Chi Minh City 50
Jiaxing 49
Ferrara 45
London 45
Tianjin 45
Rome 44
São Paulo 42
Hanoi 40
Pune 40
Guangzhou 39
Washington 39
Hebei 38
Changsha 37
Chicago 37
Falls Church 35
New York 35
Norwalk 34
Toronto 30
Sassari 28
Orange 26
Columbus 25
Council Bluffs 24
Jinan 24
Paris 24
Redondo Beach 24
Phoenix 22
Tokyo 22
Saint Petersburg 21
Ningbo 20
Brooklyn 18
Nuremberg 18
Atlanta 17
Belo Horizonte 17
Frankfurt am Main 17
Olbia 17
Phnom Penh 17
Munich 16
Rio de Janeiro 16
Brussels 15
San Francisco 15
Casablanca 14
Tappahannock 13
Zhengzhou 13
Warsaw 12
Auburn Hills 11
Borås 11
Haiphong 11
Hyderabad 11
Indiana 11
Renton 11
Stockholm 11
Vienna 11
Astana 10
Jakarta 10
Mexico City 10
Taizhou 10
Azor 9
Brasília 9
Campinas 9
Hangzhou 9
Kilburn 9
Turku 9
Biên Hòa 8
Totale 164.042
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.866
Discovery of thiazolin-4-one-based aromatic sulfamates as a new class of carbonic anhydrase isoforms I, II, IV, and IX inhibitors 2.811
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.804
Effect of the T-type channel blocker KYS-05090S in mouse models of acute and neuropathic pain 2.771
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.695
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.680
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.617
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.569
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.565
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.557
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.494
Attenuating Ischemic Disruption of K+ Homeostasis in the Cortex of Hypoxic-Ischemic Neonatal Rats: DOR Activation vs. Acupuncture Treatment 2.467
Critical role for prokineticin 2 in CNS autoimmunity 2.426
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.329
3,4-Dihydroquinazoline derivatives inhibit the activities of cholinesterase enzymes 2.281
Benzofuran hydrazones as potential scaffold in the development of multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity 2.244
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones 2.240
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.235
Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy 2.170
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.158
Antagonism of EG-VEGF receptors as targeted therapy for choriocarcinoma progression in vitro and in vivo 2.074
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazoles 2.037
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.027
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy 2.018
In-Vitro Evaluation of Antioxidant, Antiproliferative and Photo-Protective Activities of Benzimidazolehydrazone Derivatives 1.954
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.867
PC1, a non-peptide PKR1-preferring antagonist, reduces pain behavior and spinal neuronal sensitization in neuropathic mice 1.847
An important role for prokineticin 2 in autoimmune CNS demyelination 1.778
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.774
null 1.768
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.722
δ-Opioid Receptor Activation Attenuates Hypoxia/MPP+-Induced Downregulation of PINK1: a Novel Mechanism of Neuroprotection Against Parkinsonian Injury 1.637
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro 1.616
Genetically Encodable Bacterial Flavin Transferase for Fluorogenic Protein Modification in Mammalian Cells 1.577
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease 1.565
Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated 1.527
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.450
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 1.443
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model 1.432
null 1.383
Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: Focus on pain and emotional like behavior 1.379
Antagonism of EG-VEGF receptors is a novel targeted therapy for choriocarcinoma progression: in vitro, in vivo and in clinical studies 1.351
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.328
Ligand- and cell-dependent determinants and cAMP modulation by delta opioid receptor (DOR) agonists 1.325
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.295
A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation 1.291
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 1.268
The antagonism of the prokineticin system counteracts bortezomib induced side effects: Focus on mood alterations 1.256
Antagonistic Activity of Naphthoquinone-Based Hybrids toward Amyloids Associated with Alzheimer's Disease and Type-2 Diabetes 1.245
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.199
Prokineticin 1-prokineticin receptor 1 signaling promotes angiogenesis in the porcine endometrium during pregnancy 1.151
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.147
∂-opioid receptor activation protects against Parkinson’s disease-related mitochondrial dysfunction by enhancing PINK1/Parkin-dependent mitophagy 1.120
Opposite Roles of δ- and μ-Opioid Receptors in BACE1 Regulation and Alzheimer’s Injury 1.066
Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals 1.065
Evidence-Based View of Safety and Effectiveness of Prokineticin Receptors Antagonists during Pregnancy 1.011
Antidepressant-like and anxiolytic-like effects following activation of the mu-delta opioid receptor heteromer in the nucleus accumbens 936
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 892
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes 848
Delta-opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia 839
activation of the mu-delta opioid receptor heteromer produces anti-depressant-like and anxiolytic-like effects 827
null 825
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 817
Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-Alpha in the mouse cortex exposed to prolonged hypoxia 808
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 805
New features of the delta opioid receptor: conformationalproperties of deltorphin I analogues 801
Agonists at the delta-opioid receptor modify the binding of mu-receptor agonists to the mu-delta receptor hetero-oligomer 786
Prokineticin receptors antagonist PC-10 as a biomarker for imaging inflammatory pain 785
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 778
null 731
Differential inflammation-mediated function of prokineticin 2 in the synovial fibroblasts of patients with rheumatoid arthritis compared with osteoarthritis 712
Blocking prokineticin receptors attenuates synovitis and joint destruction in collagen-induced arthritis 707
Conformational dynamics of KIR3.1/KIR3.2 channel activation via delta-opioid receptors (DORs) 707
Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors 702
Structural and biological exploration of Phe3-Phe4-modified endomorphin-2 peptidomimetics 698
Hair Growth Promotion by δ-Opioid Receptor Activation 682
Hydrogen sulfide inhibits inflammatory pain and enhances the analgesic properties of delta opioid receptors 662
DOR activation inhibits anoxic/ischemic Na+ influx through Na+ channels via PKC mechanisms in the cortex 661
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues. 660
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 642
Influence of the side chain next to C-terminal benzimidazole in opioid pseudopeptides containing the Dmt-Tic pharmacophore 618
Na+ mechanism of delta-opioid receptor induced protection from K+ leakage in the cortex 608
Role of the 2',6'-dimethyl-L-tyrosine (Dmt) in some opioid lead compounds 601
Synthesis, pharmacological evaluation and conformational investigation of endomorphin-2 hybrid analogues 601
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist, correlation between desensitization and tolerance 600
Hydrogen sulfide induced disruption of Na+ homeostasis in the cortex 600
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain 579
Prokineticin System Is a Pharmacological Target to Counteract Pain and Its Comorbid Mood Alterations in an Osteoarthritis Murine Model 569
Structure-activity relatioships of tetrapeptides related to dermorphin: a 500-MHz 1H-nmr study 569
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors 554
null 546
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 540
Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 537
Orally administered H-Dmt-Tic-Lys-NH-CH2-Ph (MZ-2), a potent mu/delta-opioid receptor antagonist, regulates obese-related factors in mice 534
A Critical Role of δ-Opioid Receptor in Anti-microglial Activation Under Stress 530
Direct influence of C-terminally substituted amino acids in the Dmt-Tic pharmacophore on delta-opioid receptor selectivity and antagonism 516
Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides 516
Hydrogen Sulfide Increases the Analgesic Effects of µ- and δ-Opioid Receptors during Neuropathic Pain: Pathways Implicated 515
Synthesis of N-FmocN,N'-bis-Boc-5-,6- and 8-guanyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid (5-GTIC, 6-GTIC and 8-GTIC) 511
Prokineticin 1 is a novel factor regulating porcine corpus luteum function 509
Totale 133.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113.666 0 0 0 0 0 3.390 2.804 1.789 791 1.628 1.745 1.519
2021/20229.546 600 806 1.092 529 420 819 912 643 595 587 934 1.609
2022/202316.522 1.658 1.741 1.164 1.262 1.464 2.157 1.168 1.527 978 1.019 1.601 783
2023/202419.214 725 818 712 1.288 1.898 3.050 3.230 1.222 924 1.297 1.763 2.287
2024/202539.798 8.850 11.727 5.060 4.256 2.362 2.242 3.438 216 421 314 361 551
2025/20264.642 606 578 1.421 759 666 612 0 0 0 0 0 0
Totale 171.412